JUNO THERAPEUTICS INC (JUNO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109

Juno Therapeutics Inc operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services.

Are you looking for this stock instead?

View SEC Filings from JUNO instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding JUNO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding JUNO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASSIDY BERNARD J GENERAL COUNSEL & SECRETARY

  • Officer
No longer subject to file 2018-03-05 0

HARR STEVE CFO & HEAD, CORP. DEVELOPMENT

  • Officer
No longer subject to file 2018-03-05 0

EVNIN ANTHONY B

  • Director
No longer subject to file 2018-03-05 0

NELSEN ROBERT

  • Director
No longer subject to file 2018-03-05 0

PIEN HOWARD H

  • Director
No longer subject to file 2018-03-05 0

BISHOP HANS EDGAR CEO & PRESIDENT

  • Officer
  • Director
No longer subject to file 2018-03-05 0

WILDEROTTER MARY AGNES

  • Director
No longer subject to file 2018-03-05 0

BARRON HAL

  • Director
No longer subject to file 2018-03-05 0

KLAUSNER RICHARD

  • Director
No longer subject to file 2018-03-05 0

DANIEL THOMAS O

  • Director
No longer subject to file 2018-03-05 0

AZELBY ROBERT EVP & CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2018-03-05 0

AGARWAL SUNIL PRESIDENT OF R & D

  • Officer
No longer subject to file 2018-03-05 0

FLATLEY JAY T

  • Director
No longer subject to file 2018-03-05 0

LEE ANN L. EVP, TECHNICAL OPERATIONS

  • Officer
No longer subject to file 2018-03-05 0

CELGENE CORP /DE/

CELGENE SWITZERLAND LLC

BLUE MAGPIE CORP

  • 10% Owner
99,227,867 2018-03-05 0

BRATTON DOUGLAS K

CRESTLINE INVESTORS, INC.

CRESTLINE SI (GP), L.P.

CRESTLINE MANAGEMENT, LP

CL ALASKA, L.P.

  • 10% Owner
No longer subject to file 2017-07-13 0

VESSEY RUPERT

  • Director
0 2017-04-13 0

LEVITSKY HYAM EVP, RESEARCH & CSO

  • Officer
131,334 2017-02-07 0

TESSIER-LAVIGNE MARC

  • Director
0 2016-06-17 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
No longer subject to file 2016-03-15 0

FROHLICH MARK W SEE REMARKS

  • Officer
No longer subject to file 2016-02-29 0

BRATTON DOUGLAS K

  • 10% Owner
25,948,799 2015-07-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments